Institutional shares held 37.8 Million
116K calls
299K puts
Total value of holdings $681M
$2.09M calls
$5.38M puts
Market Cap $6.3B
350,000,000 Shares Out.
Institutional ownership 10.8%
# of Institutions 118


Latest Institutional Activity in BLCO

Top Purchases

Q3 2024
D. E. Shaw & Co., Inc. Shares Held: 1.91M ($34.5M)
Q3 2024
Diameter Capital Partners LP Shares Held: 1.1M ($19.8M)
Q3 2024
Empyrean Capital Partners, LP Shares Held: 1.24M ($22.3M)
Q3 2024
Apollo Management Holdings, L.P. Shares Held: 1.38M ($24.8M)
Q3 2024
King Street Capital Management, L.P. Shares Held: 732K ($13.2M)

Top Sells

Q3 2024
Goldentree Asset Management LP Shares Held: 3.36M ($60.4M)
Q3 2024
Rokos Capital Management LLP Shares Held: 241K ($4.34M)
Q3 2024
Whitebox Advisors LLC Shares Held: 1.24M ($22.4M)
Q3 2024
Allianz Asset Management Gmb H Shares Held: 171K ($3.08M)
Q3 2024
Maple Rock Capital Partners Inc. Shares Held: 3.62M ($65.1M)

About BLCO

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.


Insider Transactions at BLCO

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
560K Shares
From 18 Insiders
Grant, award, or other acquisition 528K shares
Open market or private purchase 32.3K shares
Sell / Disposition
35.2K Shares
From 6 Insiders
Payment of exercise price or tax liability 35.2K shares

Track Institutional and Insider Activities on BLCO

Follow Bausch & Lomb Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLCO shares.

Notify only if

Insider Trading

Get notified when an Bausch & Lomb Corp insider buys or sells BLCO shares.

Notify only if

News

Receive news related to Bausch & Lomb Corp

Track Activities on BLCO